Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

DexCom, Inc. - Common Stock (NQ:DXCM)

80.51 -0.25 (-0.31%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 5, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DexCom, Inc. - Common Stock

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
37 38 Next >
Why Apellis Pharmaceuticals Shares Are Trading Lower By Around 19%? Here Are Other Stocks Moving In Monday's Session
Gainers Yellow Corporation (NASDAQ: YELL) shares jumped 106% to $1.46. The trucking company ceased operations on Sunday, according to a Wall Street Journal report. 
Via Benzinga
Glucose Monitor Maker DexCom In Buy Zone After Gapping Higher
Strong Q2 earnings performance propelled DexCom higher. Investors cheered the glucose monitoring leader's bullish sales view and international expansion plans. 
Via MarketBeat
Skechers, Chart Industries, Roku, Beazer Homes And Other Big Stocks Moving Higher On Friday
U.S. stocks traded higher, with the Nasdaq Composite gaining around 200 points on Friday. Here are some big stocks recording gains in today’s session. Reata Pharmaceuticals, Inc. (NASDAQ: RETA) rose... 
Via Benzinga
Stock Market Rallies Amid Huge Earnings, Fed Rate Hike, Inflation Data: Weekly Review
Despite Thursday's downside reversal, the major indexes had a solid advance. 
Via Investor's Business Daily
Why DexCom Shares Are Trading Higher Today
DexCom Inc (NASDAQ: DXCM) shares are trading higher after the company reported  
Via Benzinga
6 Analysts Have This to Say About DexCom
 
Via Benzinga
DexCom (DXCM) Q2 2023 Earnings Call Transcript
DXCM earnings call for the period ending June 30, 2023. 
Via The Motley Fool
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $75,000 Today
 
Via Benzinga
Looking At DexCom's Recent Unusual Options Activity
 
Via Benzinga
Dexcom Earnings Tops Estimates, Medical Device Maker Hikes Outlook
Dexcom stock rose after the company reported Q2 earnings and revenue that topped Wall Street targets and raised full-year sales guidance. 
Via Investor's Business Daily
Dexcom Reports Second Quarter 2023 Financial Results
From DexCom, Inc.
Via Business Wire
Top Picks: 3 Stocks That (Almost) All Analysts Agree On
While you shouldn’t rely on the word of analysts, sometimes they are the best stocks to buy for the long haul. 
Via InvestorPlace
Elliott Wave Technical Analysis: DexCom Inc. - Wednesday, July 19
Looking for longs on the pullback in wave iv. 
Via Talk Markets
Wall Street Believes These High-Profile Stock-Split Stocks Can Lose Up to 91% of Their Value
The low-water price targets provided by select analysts and Wall Street institutions suggest these widely owned stock-split stocks could plunge. 
Via The Motley Fool
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
 
Via Benzinga
2 Growth Stocks That Could Double in 5 Years
They could deliver excellent returns well beyond that. 
Via The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
 
Via Benzinga
Nvidia And This AI Stock Lead 5 Names Near Buy Points
Nvidia has soared this year. Now its tight range has created a new buy point. 
Via Investor's Business Daily
Dexcom Schedules Second Quarter 2023 Earnings Release and Conference Call for July 27, 2023 at 4:30 p.m. Eastern Time
From DexCom, Inc.
Via Business Wire
A Look Into DexCom Inc's Price Over Earnings
 
Via Benzinga
Peering Into DexCom's Recent Short Interest
 
Via Benzinga
DexCom Unusual Options Activity For June 26
 
Via Benzinga
Where DexCom Stands With Analysts
 
Via Benzinga
Just 8 S&P 500 Stocks Make The Cut In Goldman's 'Rule Of 10' Screens
This elite eight meet long-term growth criteria for sales and earnings. 
Via Investor's Business Daily
Dexcom G7 Continuous Glucose Monitoring System Gets Regulatory Nod From Health Canada
DexCom, Inc.'s (NASDAQ: DXCM) next-generation  
Via Benzinga
1 Stock-Split Stock to Buy Hand Over Fist in July and 1 to Avoid Like the Plague
Among Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage, there's one phenomenal value and another top performer that's arguably never been this pricey. 
Via The Motley Fool
Dexcom G7 Receives Health Canada Approval: Next-Generation Continuous Glucose Monitoring System With Unmatched Accuracy Coming to Canadians
From Dexcom, Inc.
Via Business Wire
Goldman Sachs Reveals Winning Portfolio: 'Rule of 10' Unlocks S&P 500's Future Top Performers
 
Via Benzinga
Friday's ETF Winners And Losers: Large-Cap Fund Flows - VOO and SPY Add More Than $1.5 Billion Each
We performed a screening of large-cap ETFs - defined as having Assets Under Management (AUM) over $10 billion - to determine what funds had the largest change in net assets on the week, according to... 
Via Benzinga
Elliott Wave Technical Analysis: DexCom Inc. - Thursday, June 29
Looking for upside into wave {iii} as long as we don’t break the bottom of wave {ii}. 
Via Talk Markets
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
37 38 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.